Exagen (XGN) Total Liabilities (2018 - 2026)

Exagen (XGN) has 9 years of Total Liabilities data on file, last reported at $37.5 million in Q1 2026.

• Quarterly Total Liabilities rose 10.72% year-over-year to $37.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.5 million (up 10.72% YoY) and the FY2025 annual result came in at $40.6 million, up 15.43% from the prior year.
• Total Liabilities declined to $37.5 million in Q1 2026, from $40.6 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $45.9 million in Q1 2022 to a low of $30.7 million in Q3 2024.
• A 5-year average of $38.0 million and a median of $37.5 million in 2026 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2024 — Total Liabilities dropped 28.82% — and 2025, when it soared 45.38%.
• Tracing XGN's Total Liabilities over 5 years: stood at $43.8 million in 2022, then dropped by 21.73% to $34.2 million in 2023, then grew by 2.62% to $35.1 million in 2024, then grew by 15.43% to $40.6 million in 2025, then retreated by 7.51% to $37.5 million in 2026.
• The last three Total Liabilities figures came in at $37.5 million (Q1 2026), $40.6 million (Q4 2025), and $44.7 million (Q3 2025), per Business Quant data.